| Sarah Wrather, OTR/L | |
|
2111 Belle Haven Blvd, Bowling Green, KY 42104-7205 | |
| (270) 576-3304 | |
| Not Available |
| Full Name | Sarah Wrather |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 2111 Belle Haven Blvd, Bowling Green, Kentucky |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164814372 | NPI | - | NPPES |
| Mailing Address | Practice Location Address |
|---|---|
| Sarah Wrather, OTR/L 2111 Belle Haven Blvd, Bowling Green, KY 42104-7205 Ph: (270) 576-3304 | Sarah Wrather, OTR/L 2111 Belle Haven Blvd, Bowling Green, KY 42104-7205 Ph: (270) 576-3304 |
News Archive
The University of British Columbia has received a $7 million grant from the Bill & Melinda Gates Foundation. UBC researchers working at the Child & Family Research Institute will test new strategies for the monitoring, prevention, and treatment of pre-eclampsia.
A gene panel that looks for about 10 times the number of cancer-causing genes as panels currently used to diagnose and fine-tune treatment for a variety of cancers is effective at identifying problematic genes in the most common leukemia, investigators report.
People with a family history of male breast cancer perceive themselves to be at higher risk of developing the disease than do patients with a family history of female breast cancer; however those with male breast cancer in their families are less likely to know about or seek genetic testing than those with a family history of female breast cancer, according to a study led by researchers at the University of Louisville's James Graham Brown Cancer Center.
Gilead Sciences, Inc. has announced receipt of a Paragraph IV Certification Notice Letter advising that Teva Pharmaceuticals submitted an Abbreviated New Drug Application (ANDA) to the U.S. Food and Drug Administration (FDA) requesting permission to manufacture and market a generic version of Atripla (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg). Atripla is currently sold in the United States through a joint venture between Bristol-Myers Squibb and Gilead.
Oceana Therapeutics, a global company focused on acquiring, developing and commercializing best-in-class specialty therapeutics, today announced that the U.S. Food and Drug Administration's (FDA) Gastroenterology and Urology Devices Panel recommended approval of Solesta™ as a treatment for fecal (bowel) incontinence, a condition afflicting many Americans, primarily women.
› Verified 9 days ago
Kimberly Thompson, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 550 High St, Bowling Green, KY 42101 Phone: 270-843-3296 | |
Bri'enne Marie Greenwell, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 550 High St, Bowling Green, KY 42101 Phone: 270-843-3296 | |
Lauren Nicole Arbuckle, MS, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1053 Lovers Ln, Bowling Green, KY 42103 Phone: 502-633-1007 | |
Mrs. Sarah Houchin Moody, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 840 Albemarle Dr, Bowling Green, KY 42103 Phone: 270-202-8808 | |
Brandi Wolf, OTR Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 165 Natchez Trace Ave Ste 200, Bowling Green, KY 42103 Phone: 270-796-4698 | |
Jessica Graves, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1329 Scottsville Rd, H6, Bowling Green, KY 42104 Phone: 502-345-3365 | |
Ms. Elizabeth Cooper Porter, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 210 Traditions Ave, Bowling Green, KY 42103 Phone: 606-303-8634 Fax: 317-520-8200 |